2-甲基-6,7-二甲氧基-1,2,3,4-四氢异喹啉盐酸盐 | 16135-43-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 中文名称: 2-甲基-6,7-二甲氧基-1,2,3,4-四氢异喹啉盐酸盐
• 英文名称: 1,2,3,4-tetrahydro-2-methyl-6,7-dimethoxyisoquinoline hydrochloride
• 英文别名: 6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydro-isoquinoline; hydrochloride；6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin; Hydrochlorid；6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride；6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline;hydrochloride
• CAS: 16135-43-6
• 化学式: C₁₂H₁₇NO₂*ClH
• 分子量: 243.733
• InChiKey: PLUNNRJXHUNDQO-UHFFFAOYSA-N

物化性质

• 熔点：
  221-224 °C

计算性质

• 辛醇/水分配系数(LogP)：
  2.11
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  22.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  C
• 安全说明：
  S45
• 危险类别码：
  R34
• 海关编码：
  2933499090

反应信息

• 作为产物：
  描述：

  2-methyl-6,7-dimethoxy-3,4-dihydroisoquinolinium iodide 在 盐酸 、 三正丁基氢锡 作用下， 生成 2-甲基-6,7-二甲氧基-1,2,3,4-四氢异喹啉盐酸盐
  参考文献：
  名称：

  A Mild and Chemoselective Reduction of Cyclic Iminium Salts

  摘要：

  在室温下，通过与甲醇中的三丁基锡烷反应，N-取代环状亚胺盐可以方便地还原成相应的叔胺，而且收率很高。在这些条件下，分子中存在的各种官能团（如酮基）不会受到影响。

  DOI：

  10.1055/s-1985-31434

文献信息

• Cephem Compounds with Latent Reactive Groups
  申请人：Gladius Pharmaceuticals, Inc.

  公开号：US20190100534A1

  公开（公告）日：2019-04-04

  Cephem and penem compounds having a styrylmethylene moiety at the 3-position in the cephem or penem ring to which a positively charged leaving group is bonded and wherein the leaving group contains a vicinal diol or is bonded to a unsubstituted or substituted catechol. The leaving group can be a positively charge nitrogen leaving group. Cephems include cephalosporins, cephamycins, carbacephems, and oxacephems. Penems include penems, carbapenems and oxapenems. Preferred cephems are cephalosporins. Preferred penems are carbapenems. Compounds exhibit antibiotic activity against Gram-negative bacteria and/or Gram-positive bacteria. Compounds exhibit antibiotic activity against bacteria which exhibit multi-drug resistance. Compounds of the invention exhibit antibiotic activity against bacterial strains which produce extended spectrum beta-lactamases (ESBL), which produce AmpC beta-lactamases or which produce a carbapenemase. Pharmaceutical compositions comprising one or more cephems or penems or methods of treatment of bacterial infections with such compounds and compositions.

  具有在头孢菌素或青霉烷素环中3位处具有苯乙烯亚甲基基团的头孢菌素和青霉烷素化合物，其中正电离子离去基团与离去基团中含有邻二醇或连接到未取代或取代过的邻苯二酚。离去基团可以是正电离子离去基团。头孢菌素包括头孢菌素、头孢菌烷、卡巴头孢菌素和氧头孢菌素。青霉烷素包括青霉烷素、碳青霉烷素和氧青霉烷素。首选头孢菌素是头孢菌素。首选青霉烷素是碳青霉烷素。化合物对革兰氏阴性细菌和/或革兰氏阳性细菌表现出抗生素活性。化合物对表现出多重耐药性的细菌表现出抗生素活性。本发明的化合物表现出抗生素活性，对产生扩展谱β-内酰胺酶（ESBL）、产生AmpCβ-内酰胺酶或产生碳青霉烷酶的细菌菌株表现出抗生素活性。包括一种或多种头孢菌素或青霉烷素的制药组合物或使用这些化合物和组合物治疗细菌感染的方法。
• PALMISANO, G.;LESMA, G.;NALI, M.;RINDONE, B.;TOLLARI, S., SYNTHESIS, 1985, N 11, 1072-1074
  作者：PALMISANO, G.、LESMA, G.、NALI, M.、RINDONE, B.、TOLLARI, S.

  DOI：——

  日期：——
• [EN] CEPHEM COMPOUNDS WITH LATENT REACTIVE GROUPS<br/>[FR] COMPOSÉS DE CÉPHÈME AYANT DES GROUPES RÉACTIFS LATENTS
  申请人：GLADIUS PHARMACEUTICALS CORP

  公开号：WO2019070973A1

  公开（公告）日：2019-04-11

  Cephem and penem compounds having a styrylmethylene moiety at the 3-position in the cephem or penem ring to which a positively charged leaving group is bonded and wherein the leaving group contains a vicinal diol or is bonded to a unsubstituted or substituted catechol. The leaving group can be a positively charge nitrogen leaving group. Cephems include cephalosporins, cephamycins, carbacephems, and oxacephems. Penems include penems, carbapenems and oxapenems. Preferred cephems are cephalosporins. Preferred penems are carbapenems. Compounds exhibit antibiotic activity against Gram-negative bacteria and/or Gram-positive bacteria. Compounds exhibit antibiotic activity against bacteria which exhibit multi-drug resistance. Compounds of the invention exhibit antibiotic activity against bacterial strains which produce extended spectrum beta-lactamases (ESBL), which produce AmpC beta-lactamases or which produce a carbapenemase. Pharmaceutical compositions comprising one or more cephems or penems or methods of treatment of bacterial infections with such compounds and compositions.